Publications by authors named "Carolynn Francavilla Brown"
Background: In 2023, the Obesity Medicine Association (OMA) published "Compounded peptides: An Obesity Medicine Association Position Statement." Since this publication, the use of compounded peptides for the treatment of obesity has continued to evolve, leading to additional confusion and questions from obesity medicine clinicians and their patients.
Methods: This frequently asked questions (FAQ) document and "Call for Action" commentary is based upon the existing evidence and practical clinical experiences of the authors.
Article Synopsis
- This joint clinical perspective by the Obesity Medicine Association (OMA) and Obesity Action Coalition (OAC) highlights the importance of advocacy for improving the lives of people living with obesity and outlines ways for clinicians to engage in these efforts.
- The perspective is based on scientific evidence and clinical experiences from seasoned professionals, emphasizing the role of both organizations in addressing the needs of individuals affected by obesity.
- Advocacy aims to raise public awareness and influence policies to reduce bias and discrimination against those with obesity, ultimately empowering patients and clinicians to drive positive changes in health care and societal attitudes.